Molecular, haemodynamic, and functional effects of LSD in the human brain

In this study, we provide the first study to integrate molecular and functional neuroimaging during psychedelic drug effects in humans. Using simultaneous PET-MRI technology, we describe multiple brain actions of lysergic acid diethylamide (LSD) in healthy volunteers. We quantify the occupancy of LSD at cerebral serotonin 2A receptors and show that LSD increases global cerebral blood flow and internal carotid artery flow without affecting the diameter of the internal carotid artery, opposite effects to those observed In this study, we provide the fi rst study to integrate molecular and functional neuroimaging during psychedelic drug eff ects in humans. Using simultaneous PET-MRI technology, we describe multiple brain actions of lysergic acid diethylamide (LSD) in seven healthy volunteers blinded to LSD dose received. We quantify the occupancy of LSD at cerebral serotonin 2A receptors and show that LSD increases global cerebral blood fl ow (CBF) and internal carotid artery fl ow without aff ecting the diameter of the internal carotid artery, opposite eff ects to those observed following psilocybin. Functional connectivity analyses show decreases in global connectivity (GCOR). Change in GCOR is negatively correlated with change in CBF. We observe an anticlockwise hysteresis loop between plasma drug levels and subjective eff ects, suggesting atypical pharmacodynamic mechanisms. We contrast our CBF and GCOR fi ndings and their relation in a separate cohort of 25 participants administered psilocybin, highlighting key consistencies and diff erences in their neural eff ects. By establishing the dose-occupancy relation of LSD in humans, our fi ndings provide critical insights for the clinical development of psychedelic compounds and demonstrate unique neurophysiological eff ects that distinguish LSD from related psychedelics.